L. E. Dodd, Follmann, D., Wang, J., Koenig, F., Korn, L. L., Schoergenhofer, C., Proschan, M., Hunsberger, S., Bonnett, T., Makowski, M., Belhadi, D., Wang, Y., Cao, B., Mentre, F., and Jaki, T.,
“Endpoints for randomized controlled clinical trials for COVID-19 treatments.”,
Clin Trials, vol. 17, no. 5, pp. 472-482, 2020.
]